Analyst Reco. GoHealth, Inc.

Equities

GOCO

US38046W2044

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
9.01 ^USD	-4.35%		-10.88%	-32.46%

May. 09	GoHealth, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 09	Transcript : GoHealth, Inc., Q1 2024 Earnings Call, May 09, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RBC Cuts Price Target on GoHealth to $13 From $20, Notes 'Diminished Topline Visibility' in Near Term; Sector Perform Kept	Mar. 20	MT
RBC Raises PT on GoHealth to $20 From $15 After 'Solid' Q2 Results, Says Encompass Gains Momentum Ahead of Annual Enrollment Period; Sector Perform Kept	23-08-14	MT
RBC Raises Price Target on GoHealth to $15 From $14, Maintains Sector Perform Rating	23-05-12	MT
Credit Suisse Raises GoHealth's Price Target to $8.50 From $7 After Model Update; Keeps Underperform Rating	23-04-04	MT
RBC Cuts Price Target on GoHealth to $14 From $15 After Q4 Miss Amid Negative Revenue Lookback Adjustment; Sector Perform Kept	23-03-17	MT
Credit Suisse Adjusts GoHealth's Price Target to $7 From $18.75, Retains Underperform Rating	22-11-23	MT
RBC Capital Adjusts GoHealth's Price Target to $1 From $2, Maintains Sector Perform Rating	22-08-26	MT
Evercore ISI Adjusts GoHealth's Price Target to $1.75 from $4.50, Keeps In Line Rating	22-03-16	MT
Morgan Stanley Adjusts GoHealth Price Target to $1 From $3, Maintains Equalweight Rating	22-03-16	MT
RBC Downgrades GoHealth to Sector Perform From Outperform, Slashes Price Target to $2 From $10, Citing 'Sea Change in Operating Backdrop'	22-03-03	MT
Truist Securities Downgrades GoHealth to Hold from Buy, Lowers Price Target to $2 From $6	22-03-02	MT
Barclays Adjusts Price Target for GoHealth to $3 From $5, Maintains Equalweight Rating	22-01-18	MT
Credit Suisse Downgrades GoHealth to Underperform from Neutral, Says Among Potential M&A Targets; Lowers PT to $3 from $6	22-01-07	MT
BofA Securities Double Downgrades GoHealth to Underperform from Buy, Adjusts Price Target to $3.50 from $7.50; Shares Drop 12%	22-01-05	MT
Evercore ISI Lowers Price Target for GoHealth to $4.50 From $7.50, Maintains In-Line Rating	22-01-04	MT
Morgan Stanley Adjusts Price Target on GoHealth to $5.50 from $13, Keeps Equalweight Rating	21-11-11	MT
Truist Lowers Price Target for GoHealth to $6 From $11, Maintains Buy Rating	21-11-10	MT
RBC Cuts Price Target on GoHealth to $10 From $17, Citing Sector Rerating, Maintains Outperform Rating	21-11-10	MT
Barclays Downgrades GoHealth to Equalweight from Overweight, Adjusts Price Target to $5 from $10	21-11-09	MT
GOHEALTH : Barclays Adjusts GoHealth's Price Target to $10 from $18, Keeps Overweight Rating	21-08-13	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. GoHealth, Inc.

Equities

GOCO

US38046W2044

Analyst Reco.

Filters